chlorambucil

Trials studying chlorambucil

• phase3A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)active not recruitingn=211
• phase3Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemiaactive not recruitingn=155
• phase3Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemiacompletedn=445
• phase3Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLLactive not recruitingn=535
• phase3Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemiaterminatedn=603
• phase3A Global Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.recruitingn=344
• phase3ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLLunknownn=218